In DEC-induced DNA reprogramming, chimeric antigen receptor T (CAR T) cells, compared to the control group, differentially expressed genes including AKT3, and it is expected that this can enhance antitumor effects or reduce tumor recurrence [46]. This evidence concerns the gene AKT3 and neoplasm.